Sumatriptan Tablet
Product Images NDC 63187-969

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph showing the estimated probability of response over time in minutes from the initial dose for different dosages of Sumatriptan Succinate tablets (placebo, 25 mg, 50 mg, 100 mg). The graph compares response rates across these dosage groups up to 240 minutes post-dose.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

A line graph showing the estimated probability of headache pain remediation or rescue over 24 hours following the initial dose. Four curves represent placebo and three strengths of Sumatriptan (25 mg, 50 mg, and 100 mg), with higher doses generally showing increased probability of efficacy over time.*

FDA Label Image

63187-969-09 (Sumatriptan Fig3)

Label for Sumatriptan 25 mg tablets by Proficient Rx LP. Each tablet contains sumatriptan succinate USP equivalent to 25 mg sumatriptan, white to off-white round biconvex uncoated tablets debossed with 'C' and '32'. Label includes NDC 63187-969-09, barcodes, and manufacturer Aurobindo Pharma Limited, Hyderabad, India.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of Sumatriptan Succinate, showing its molecular components including a sulfonamide group, an indole ring, and a succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.